Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Robertson C, Arcot Ragupathy SK, Boachie C, et al. The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation. Southampton (UK): NIHR Journals Library; 2011 Sep. (Health Technology Assessment, No. 15.34.)
The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation.
Show detailsMEDLINE (1990 – March, week 1, 2009), EMBASE (1990–2009, week 11)
MEDLINE In-Process (13 March 2009)
Ovid multifile search: https://shibboleth.ovid.com/
- exp *breast neoplasms/use mesz
- exp *breast tumor/use emez
- breast.ti.
- or/1–3
- neoplasm recurrence, local/use mesz
- tumor recurrence/use emez
- cancer recurrence/use emez
- neoplasms, second primary/use mesz
- second cancer/use emez
- (recur$ or second or secondary or contralateral or ipsilateral or ibtr or mcbc).tw.
- or/5–10
- exp mammography/
- (mammograph$ or mammogram$).tw.
- physical examination/
- breast self-examination/
- breast examination/use emez
- ((physical or clinical or self) adj1 (exam? or examin$)).tw.
- surveillance.hw,tw.
- follow up.ti.
- (routine adj3 (visit or follow up)).tw.
- Magnetic resonance imaging/use mesz
- Nuclear Magnetic resonance imaging/use emez
- (magnetic resonance imag$ or mri).tw.
- ultrasonography, mammary/use mesz
- echomammography/use emez
- (ultrasound or ultrasonograph$ or echo mammogra$or echomammogra$).tw.
- or/12–26
- neoplasm recurrence, local/di use mesz
- tumor recurrence/di use emez
- cancer recurrence/di use emez
- neoplasms, second primary/di use mesz
- second cancer/di use emez
- or/28–32
- 4 and 33
- “sensitivity and specificity”/
- roc curve/
- receiver operating characteristic/use emez
- predictive value of tests/
- diagnostic errors/use emez
- false positive reactions/use mesz
- false negative reactions/use mesz
- diagnostic accuracy/use emez
- diagnostic value/use emez
- du.fs. use mesz
- sensitivity.tw.
- distinguish$.tw.
- differentiat$.tw.
- identif$.tw.
- detect$.tw.
- diagnos$.tw.
- (predictive adj4 value$).tw.
- accura$.tw.
- comparison.tw.
- or/35–53
- 27 and 11 and 4 and 54
- 34 or 55
- remove duplicates from 56
- limit 57 to yr=“1990 – 2009”
- limit 58 to english language
Science Citation Index (1990 – 14 March 2009), BIOSIS (1990 – 12 March 2009)
ISI Web of Knowledge:http://wok.mimas.ac.uk/
- # 1.
TS=(breast neoplasm* AND (recur* or secondary or contralateral or ipsilateral or ibtr or mcbc))
- # 2.
TS=(breast cancer* AND (recur* or secondary or contralateral or ipsilateral or ibtr or mcbc))
- # 3.
TS=(breast carcin* AND (recur* or secondary or contralateral or ipsilateral or ibtr or mcbc))
- # 4.
TS=(breast tumour* AND (recur* or secondary or contralateral or ipsilateral or ibtr or mcbc))
- # 5.
TS=(breast tumor* AND (recur* or secondary or contralateral or ipsilateral or ibtr or mcbc))
- # 6.
#1 or #2 or #3 or #4 or #5
- # 7.
#6 AND TS=mammogram*
- # 8.
#6 AND TS=mammograph*
- # 9.
#6 and TS=surveillance
- # 10.
#6 and TS=routine
- # 11.
#6 and TS=magnetic resonance imag*
- # 12.
#6 AND TS=mri
- # 13.
#6 and TS=ultrasound
- # 14.
#6 and TS=ultrasonograph*
- # 15.
#6 and TS=echo mammogra*
- # 16.
#6 and TS=echomammogra*
- # 17.
#6 and TS= (cliniCAL EXAM* OR SELF EXAM* OR PHYSICAL EXAM*)
- # 18.
#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17
- # 19.
#18 AND TS=(sensitivity or specificity)
- # 20.
#18 AND TS=(ROC or receiver operat* characteristic)
- # 21.
#18 AND TS=(diagnos* or detect*)
- # 22.
#18 AND TS=(differentiat* or distinguish*)
- # 23.
#18 AND TS=(accura* or identif*)
- # 24.
#23 OR #22 OR #21 OR #20 OR #19 AND Language=(English) AND Document Type=(Article)
Databases=SCI-EXPANDED Timespan=1990–2009
Cochrane Library Issue 2, 2009 (Cochrane Central Registry of Controlled Trials and Cochrane Database of Systematic Reviews)
www3.interscience.wiley.com/
- # 1.
MeSH descriptor Breast Neoplasms explode all trees
- # 2.
(breast):ti
- # 3.
(#1 OR #2)
- # 4.
MeSH descriptor Neoplasm Recurrence, Local, this term only
- # 5.
MeSH descriptor Neoplasms, Second Primary, this term only
- # 6.
(recur* or second or secondary):ti,ab,kw or (contralateral or ipsilateral):ti,ab,kw or (ibtr or mcbc):ti,ab,kw
- # 7.
(#4 OR #5 OR #6)
- # 8.
MeSH descriptor Mammography explode all trees
- # 9.
(mammograph* or mammogram*):ti,ab,kw
- # 10.
MeSH descriptor Physical Examination, this term only
- # 11.
MeSH descriptor Breast Self-Examination, this term only
- # 12.
(physical NEAR/1 exam*):ti,ab,kw or (clinical NEAR/1 exam*):ti,ab,kw or (self NEAR/1 exam*):ti,ab,kw
- # 13.
(surveillance):ti,ab,kw or (follow up):ti or (routine NEAR/3 visit*):ti,ab,kw or (routine NEAR/3 follow up):ab
- # 14.
MeSH descriptor Magnetic Resonance Imaging, this term only
- # 15.
MeSH descriptor Ultrasonography, Mammary, this term only
- # 16.
(magnetic resonance imag* or mri):ti,ab,kw or (ultrasound or ultrasonograph*):ti,ab,kw or (echo mammogra* or echomammogra*):ti,ab,kw
- # 17.
(#8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16)
- # 18.
(#3 AND #7 AND #17)
- # 19.
MeSH descriptor Neoplasm Recurrence, Local explode all trees with qualifier: DI
- # 20.
MeSH descriptor Neoplasms, Second Primary explode all trees with qualifier: DI
- # 21.
(#3 AND (#19 OR #20))
- # 22.
#18 OR #21 (1990–2009)
CANCERLIT (20 March 2009)
The US National Library of Medicine: www.ncbi.nlm.nih.gov
- # 1.
Search (breast neoplasms[majr] AND human[mh] AND english[la]) OR dcis[ti] OR lcis[ti] OR ((breast[ti] OR breasts[ti] OR mammary[ti] OR nipple[ti] OR nipples[ti]) AND ((cancer*[ti] OR carcinoma*[ti] OR adenocarcinoma*[ti] OR malignan*[ti] OR tumor*[ti] OR tumour*[ti] OR neoplasm*[ti]) OR in situ[ti])) Limits: Cancer
- # 2.
Search recur* or secondary or contralateral or ipsilateral or ibtr or mcbc Limits: Cancer
- # 3.
Search #1 AND #2 Limits: Cancer
- # 4.
Search ((((Magnetic resonance imaging[MeSH Terms]) OR (ultrasonography, mammary[MeSH Terms])) OR (“magnetic resonance imag* or mri”[Text Word])) OR (“ultrasound or ultrasonograph* or echo mammogra* or echomammogra*”[Text Word])) AND (#1 AND #2) Limits: English
Health Technology Assessment/Database of Abstracts of Reviews and Effects/NHS Economic Evaluation databases, March 2009
Centre for Reviews & Dissemination: http://nhscrd.york.ac.uk/welcome.htm
- # 1.
MeSH Breast Neoplasms EXPLODE 1 2
- # 2.
(recur* OR ipsilateral OR contralateral OR ibtr OR mcbc OR second OR secondary)
- # 3.
#1 and #2
MEDION, March 2009
Clinical Trials, March 2009
http://clinicaltrials.gov/ct/gui/c/r
“Breast neoplasms”
AND
Mammography OR ultrasonography OR magnetic resonance imaging
AND
Recurrence or ipsilateral or ccontralateral or ibtr or mcbc
Current Controlled Trials, March 2009
www.controlled-trials.com/
Breast AND (mammography OR magnetic resonance imaging OR ultrasonography)
The World Health Organization International Clinical Trials Registry Platform, March 2009
World Health Organization: www.who.int/ictrp/en/
Breast AND (mammography OR magnetic resonance imaging OR ultrasonography)
National Research Register Archive
National Institute for Health Research portal: https://portal.nihr.ac.uk/Pages/NRRArchiveSearch.aspx
NIHR portfolio, March 2009
National Institute for Health Research portal: https://portal.nihr.ac.uk/Search/Advanced.aspx
Breast AND (mammography OR magnetic resonance imaging OR ultrasonography)
National Cancer Institute Clinical Trials, March 2009
The US National Institutes of Health: www.cancer.gov
breast cancer (female) AND mammography OR magnetic resonance imaging OR ultrasonography
Websites consulted
American College of Radiology
American Society of Breast Disease
American Society of Clinical Oncology
Breast Cancer Surveillance Consortium
http://breastscreening.cancer.gov/
CancerWEB
Canadian Task Force on Preventive Health Care
Cancer Research UK
European Society for Medical Oncology
National Breast and Ovarian Cancer Centre
National Cancer Institute
www.cancer.gov/cancertopics/types/breast
National Comprehensive Cancer Network
National Library for Health
www.library.nhs.uk/default.aspx
Royal College of Radiologists
Surveillance, Epidemiology, and End Results (SEER) Program
- MEDLINE (1990 – March, week 1, 2009), EMBASE (1990–2009, week 11): MEDLINE In-Process (13 March 2009)
- Science Citation Index (1990 – 14 March 2009), BIOSIS (1990 – 12 March 2009)
- Cochrane Library Issue 2, 2009 (Cochrane Central Registry of Controlled Trials and Cochrane Database of Systematic Reviews)
- CANCERLIT (20 March 2009)
- Health Technology Assessment/Database of Abstracts of Reviews and Effects/NHS Economic Evaluation databases, March 2009
- MEDION, March 2009
- Clinical Trials, March 2009
- Current Controlled Trials, March 2009
- The World Health Organization International Clinical Trials Registry Platform, March 2009
- National Research Register Archive
- National Cancer Institute Clinical Trials, March 2009
- Websites consulted
- Search strategies: systematic review of test performance of surveillance mammogr...Search strategies: systematic review of test performance of surveillance mammography and comparator tests in detecting IBTR/MCBC - The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation
Your browsing activity is empty.
Activity recording is turned off.
See more...